Identity and synonyms
Catalog label is recorded; analytical identity and equivalence are not established.
Peptide or peptide-related · Peptide or peptide derivative
Detailed molecular class: Peptide or peptide-derivative label; see identity
Supplied sequence or chemical reference
Mechanism
Hypocretin-2/orexin B is distinct from orexin A; affinities/stability are not interchangeable.
Evidence and critical reading
Reported scientific and empirical uses
Sleep and circadian rhythms
Included because wakefulness/nootropic agents are offered, without adopting claims as clinical indications.
Human evidence
The bounded orexin-B + healthy + humans search retrieved no MED records. Intranasal orexin A trials are not evidence for the same B regimen.
Preclinical evidence
Do not equate mechanism, cell culture or animal work with a clinical outcome. The specific level is detailed in the evidence assessment.
Critical reading and limitations
The bounded orexin-B + healthy + humans search retrieved no MED records. Intranasal orexin A trials are not evidence for the same B regimen.
The bounded orexin-B + healthy + humans search retrieved no MED records. Intranasal orexin A trials are not evidence for the same B regimen.
Source-specific regimens
Descriptive source observations, not individual recommendations.
Regulatory product labeling
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Human-study exposure
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Empirical handbook
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Regulation and safety
Jurisdiction-specific regulatory context
This record does not verify FDA/EMA authorization of the commercial identity. Where a specific medicine/product exists, jurisdiction/indication are detailed in cited sources; they do not transfer to supplier material.
Adverse effects and unknowns
No verifiable human regimen was found in this set; absence of cardiovascular/neurological effects cannot be concluded.
Contraindications
A complete list must match the exact authorized product. For experimental materials without verified human labeling, a complete contraindication set is not established here. No list does not mean safety.
Interactions
Separate documented interaction, pharmacologic plausibility and unknown interaction. Absence of a blend trial does not establish compatibility.
Studies and trials
Selected studies
No selected studies are attributed in this record.
Trials attributed in the package
No trials are attributed in this record.
Trial registration does not establish efficacy or validate commercial material.
Query candidates; attribution pending
Orexin B · 79 unfiltered query results, not authenticated trials
Query verification: October 16, 2026
Exact phrase intervention query; first three most recently updated records, not exhaustive. Aliases may be missed and heterogeneous products may appear. The total is the unfiltered registry query count, not authenticated trials. Source-integrity holds are excluded from ordinary listings.
View trial registry queryNCT07830303 · Daridorexant for Sleep Disturbance in Adults With Liver CirrhosisRegistry status: Not yet recruitingLast update posted: October 16, 2026Query verification: October 16, 2026
NCT06679062 · Suvorexant for Treatment of AUD and PTSDRegistry status: RecruitingLast update posted: October 14, 2026Query verification: October 16, 2026
NCT07407400 · Lemborexant for Sleep and Delirium Prevention in Elderly ICU PatientsRegistry status: RecruitingLast update posted: October 8, 2026Query verification: October 16, 2026
Source issues and references
References include queries and bibliographic handbook attributions; not all are clinical studies. Human review remains pending.
- SEARCH-PUBMED-orexin-b
PubMed/MED targeted search: TITLE_ABS:"orexin-B" AND TITLE_ABS:healthy AND TITLE_ABS:humans
October 16, 2026
- pdf07
US Peptide MangerCorp(1).pdf
October 16, 2026